Michael Scherbakov

Waver, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Incidence of skin and soft-tissue infections in England: 11-year retrospective study.

Incidence of skin and soft-tissue infections in England: 11-year retrospective study.

Journal: Epidemiology and infection

Published: May 26, 2026

Incidence of skin and soft tissue infections in England: 11-year retrospective study.

Incidence of skin and soft tissue infections in England: 11-year retrospective study.

Journal: Epidemiology and infection

Published: May 26, 2026

Clinical and economic burden of otitis media in children under 5 years of age in the United States: A retrospective study.

Clinical and economic burden of otitis media in children under 5 years of age in the United States: A retrospective study.

Journal: Human vaccines & immunotherapeutics

Published: October 18, 2024

The Incidence of Skin and Soft Tissue Infections in the United States and Associated Healthcare Utilization Between 2010 and 2020.

The Incidence of Skin and Soft Tissue Infections in the United States and Associated Healthcare Utilization Between 2010 and 2020.

Journal: Open forum infectious diseases

Published: March 14, 2024

Systematic review of the efficacy, effectiveness and impact of high-valency pneumococcal conjugate vaccines on otitis media.

Systematic review of the efficacy, effectiveness and impact of high-valency pneumococcal conjugate vaccines on otitis media.

Journal: Human vaccines & immunotherapeutics

Published: January 12, 2022

A randomized trial assessing the efficacy, immunogenicity, and safety of vaccination with live attenuated varicella zoster virus-containing vaccines: ten-year follow-up in Russian children.

A randomized trial assessing the efficacy, immunogenicity, and safety of vaccination with live attenuated varicella zoster virus-containing vaccines: ten-year follow-up in Russian children.

Journal: Human vaccines & immunotherapeutics

Published: August 26, 2021

Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study.

Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study.

Journal: Human vaccines & immunotherapeutics

Published: August 27, 2020

Underlying factors in paediatric invasive pneumococcal disease in Belgium.

Underlying factors in paediatric invasive pneumococcal disease in Belgium.

Journal: The Lancet. Infectious diseases

Published: August 21, 2020

Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label study.

Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label study.

Journal: Human vaccines & immunotherapeutics

Published: February 13, 2020

Showing 1-9 of 9

Last Updated: 09/26/2026